QRxPharma resubmits MoxDuo NDA

QRxPharma Ltd. (ASX:QRX; OTCQX:QRXPY) resubmitted an NDA to FDA for MoxDuo IR morphine/oxycodone to treat moderate to severe acute pain. The application contains additional data requested by FDA, incl...